Korean biopharmaceutical company Adel announced Monday that it has secured a license-out agreement worth up to $1.04 billion ...

For much of the past century, Alzheimer's disease has been one of medicine's most daunting frontiers—biologically complex, ...

Professor Peter Nestorfrom theQueensland Brain Institute's Clem Jones Centre for Ageing Dementia Research said 12 people with Alzheimer's were divided into groups to test different levels of ...

New research from the University of Virginia shows that even mild head injuries can quietly alter the brain for years.

In the last few years, progress has been made in the fight against Alzheimer's disease with a class of therapies called ...

South Korea-based ADEL said late on Monday that it has entered a $1.04 billion partnership with French drugmaker Sanofi to ...

With a grant from the Centers for Disease Control and Prevention, health officials will promote strategies to reduce dementia ...

Washington State University researchers are using AI and simulations to pinpoint a single molecular interaction that blocks ...

British researchers said the findings, published in The Lancet Psychiatry, could give doctors a potential tool to spot those ...

A new multicenter study led by Mayo Clinic researchers has established a practical, evidence-based definition of rapidly ...

Sanofi is back with its second pact of the day, this time announcing a licensing deal for a South Korean biotech’s antibody ...

UVA researchers found even minor trauma can disrupt the brain’s cleanup system, allowing harmful proteins to build up over ...